Diabetes mellitus and visual impairment: National health and nutrition examination survey, 1999-2004

Archives of Ophthalmology

Volumn 126, Issue 10, 2008, Pages 1421-1427

  Zhang, Xinzhi ^a   Gregg, Edward W ^a   Cheng, Yiling J ^a   Thompson, Theodore J ^a   Geiss, Linda S ^a   Duenas, Michael R ^a   Saaddine, Jinan B ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ETHNIC GROUP; FEMALE; HEALTH INSURANCE; HEALTH SURVEY; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VISUAL IMPAIRMENT;

ADULT; AGE DISTRIBUTION; AGED; CASE-CONTROL STUDIES; COMORBIDITY; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREVALENCE; PROBABILITY; PROGNOSIS; REFERENCE VALUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; UNITED STATES; VISION DISORDERS;

EID: 54049143303     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.126.10.1421     Document Type: Article

References (74)

1. Centers for Disease Control and Prevention. National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2005. http://www.cdc.gov/diabetes/pubs/factsheet05.htm. Accessed November 19, 2006.
2. Narayan KM, Boyle JP, Geiss LS, Saaddine JB, Thompson TJ. Impact of recent increase in incidence on future diabetes burden: US, 2005 Diabetes Care. 2006;29(9):2114-2116.
3. Lee DJ, Gomez-Marin O, Lam BL, Zheng DD, Jane DM. Trends in visual acuity impairment in US adults: the 1986-1995 National Health Interview Survey. Arch Ophthalmol. 2004;122(4):506-509.
4. Fong DS, Aiello L, Gardner TW, et al; American Diabetes Association. Retinopathy in diabetes. Diabetes Care. 2004;27(suppl 1):S84-S87.
5. Congdon N, O'Colmain B, Klaver CC, et al; Eye Diseases Prevalence Research Group. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004;122(4):477-485.
6. Hovind P, Tarnow L, Rossing K, et al. Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care. 2003;26(4):1258-1264.
7. Klein BE, Klein R, Lee KE. Diabetes, cardiovascular disease, selected cardiovascular disease risk factors, and the 5-year incidence of age-related cataract and progression of lens opacities: the Beaver Dam Eye Study. Am J Ophthalmol. 1998;126(6):782-790.
8. Leske MC, Wu SY, Hennis A, Connell AM, Hyman L, Schachat A. Diabetes, hypertension, and central obesity as cataract risk factors in a black population: the Barbados Eye Study. Ophthalmology. 1999;106(1):35-41.
9. Rowe NG, Mitchell PG, Cumming RG, Wans JJ. Diabetes, fasting blood glucose and age-related cataract: the Blue Mountains Eye Study. Ophthalmic Epidemiol. 2000;7(2):103-114.
10. Klein BE, Klein R, Jensen SC. Open-angle glaucoma and older-onset diabetes: the Beaver Dam Eye Study. Ophthalmology. 1994;101(7):1173-1177.
11. Mitchell P, Smith W, Chey T, Healey PR. Open-angle glaucoma and diabetes: the Blue Mountains Eye Study, Australia. Ophthalmology. 1997;104(4):712-718.
12. Centers for Disease Control and Prevention (CDC). Correctable visual impairment among persons with diabetes - United States, 1999-2004. MMWR Morb Mortal Wkly Rep. 2006;55(43):1169-1172.
13. Vitale S, Cotch MF, Sperduto RD. Prevalence of visual impairment in the United States. JAMA. 2006;295(18):2158-2163.
14. Klein R, Klein BE, Moss SE. Visual impairment in diabetes. Ophthalmology. 1984;91(1):1-9.
15. Moss SE, Klein R, Klein BE. The 14-year incidence of visual loss in a diabetic population. Ophthalmology. 1998;105(6):998-1003.
16. Saaddine JB, Narayan KM, Engelgau MM, Aubert RE, Klein R, Beckles GL. Prevalence of self-rated visual impairment among adults with diabetes. Am J Public Health. 1999;89(8):1200-1205.
17. National Center for Health Statistics. National Health and Nutrition Examination Survey: NHANES 1999-2004. http://www.cdc.gov/nchs/nhanes.htm. Accessed November 2006.
18. Attebo K, Mitchell P, Smith W. Visual acuity and the causes of visual loss in Australia: the Blue Mountains Eye Study. Ophthalmology. 1996;103(3):357-364.
19. Hyman L, Wu SY, Connell AM, et al. Prevalence and causes of visual impairment in the Barbados Eye Study. Ophthalmology. 2001;108(10):1751- 1756.
20. Klaver CC, Wolfs RC, Vingerling JR, Hofman A, de Jong PT. Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol. 1998;116(5):653-658.
21. Klein R, Kein BE, Linton KL, DeMets DL. The Beaver Dam Eye Study: visual acuity. Ophthalmology. 1991;98(8):1310-1315.
22. Tielsch JM, Sommer A, Witt K, Katz J, Royall RM. Blindness and visual impairment in an American urban population: the Baltimore Eye Survey. Arch Ophthalmol. 1990;108(2):286-290.
23. Age-Related Eye Disease Study Research Group. Risk factors associated with age-related macular degeneration. Ophthalmology. 2000;107(12):2224-2232.
24. Adler AI, Stratton IM, Neil HA, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ. 2000;321(7258):412-419.
25. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317(7160):703-713.
26. Wong TY, Mitchell P. The eye in hypertension [published correction appears in Lancet. 2007;369(9579):2078]. Lancet. 2007;369(9559):425-435.
27. Cheng AC, Pang CP, Leung AT, Chua JK, Fan DS, Lam DS. The association between cigarette smoking and ocular diseases. Hong Kong Med J. 2000;6(2):195-202.
28. Klein R, Klein BE, Tomany SC, Moss SE. Ten-year incidence of age-related maculopathy and smoking and drinking: the Beaver Dam Eye Study. Am J Epidemiol. 2002;156(7):589-598.
29. Smith W, Assink J, Klein R, et al. Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology. 2001;108(4):697-704.
30. Christen WG, Glynn RJ, Ajani UA, et al. Smoking cessation and risk of age-related cataract in men. JAMA. 2000;284(6):713-716.
31. Weintraub JM, Willett WC, Rosner B, Colditz GA, Seddon JM, Hankinson SE. Smoking cessation and risk of cataract extraction among US women and men. Am J Epidemiol. 2002;155(1):72-79.
32. West S, Munoz B, Emmett EA, Taylor HR. Cigarette smoking and risk of nuclear cataracts. Arch Ophthalmol. 1989;107(8):1166-1169.
33. Stratton IM, Kohner EM, Aldington SJ, et al. UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis. Diabetologia. 2001;44(2):156-163.
34. Schaumberg DA, Christen WG, Hankinson SE, Glynn RJ. Body mass index and the incidence of visually significant age-related maculopathy in men. Arch Ophthalmol. 2001;119(9):1259-1264.
35. Seddon JM, Cote J, Davis N, Rosner B. Progression of age-related macular degeneration: association with body mass index, waist circumference, and waisthip ratio. Arch Ophthalmol. 2003;121(6):785-792.
36. Delcourt C, Michel F, Colvez A, Lacroux A, Delage M, Vernet MH. Associations of cardiovascular disease and its risk factors with age-related macular degeneration: the POLA study. Ophthalmic Epidemiol. 2001;8(4):237-249.
37. Klein BE, Klein R, Lee KE, Jensen SC. Measures of obesity and age-related eye diseases. Ophthalmic Epidemiol. 2001;8(4):251-262.
38. Kuang TM, Tsai SY, Hsu WM, Cheng CY, Liu JH, Chou P. Body mass index and age-related cataract: the Shihpai Eye Study. Arch Ophthalmol. 2005;123(8):1109-1114.
39. Weintraub JM, Willett WC, Rosner B, Colditz GA, Seddon JM, Hankinson SE. A prospective study of the relationship between body mass index and cataract extraction among US women and men. Int J Obes Relat Metab Disord. 2002;26(12):1588-1595.
40. Brown MM, Brown GC, Sharma S, Landy J, Bakal J. Quality of life with visual acuity loss from diabetic retinopathy and age-related macular degeneration. Arch Ophthalmol. 2002;120(4):481-484.
41. Ivers RQ, Cumming RG, Mitchell P, Attebo K. Visual impairment and falls in older adults: the Blue Mountains Eye Study. J Am Geriatr Soc. 1998;46(1):58-64.
42. Vu HT, Keeffe JE, McCarty CA, Taylor HR. Impact of unilateral and bilateral vision loss on quality of life. Br J Ophthalmol. 2005;89(3):360-363.
43. West SK, Munoz B, Rubin GS, et al. Function and visual impairment in a population-based study of older adults: the SEE project. Salisbury Eye Evaluation. Invest Ophthalmol Vis Sci. 1997;38(1):72-82.
44. Coleman AL, Yu F, Keeler E, Mangione CM. Treatment of uncorrected refractive error improves vision-specific quality of life. J Am Geriatr Soc. 2006;54(6):883-890.
45. Evans BJ, Rowlands G. Correctable visual impairment in older people: a major unmet need. Ophthalmic Physiol Opt. 2004;24(3):161-180.
46. Wang JJ, Mitchell P, Smith W, Cumming RG, Attebo K. Impact of visual impairment on use of community support services by elderly persons: the Blue Mountains Eye Study. Invest Ophthalmol Vis Sci. 1999;40(1):12-19.
47. Wang JJ, Mitchell P, Simpson JM, Cumming RG, Smith W. Visual impairment, age-related cataract, and mortality. Arch Ophthalmol. 2001;119(8):1186-1190.
48. Kempen JH, O'Colmain BJ, Leske MC; et al; The Eye Diseases Prevalence Research Group. The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol. 2004;122(4):552-563.
49. Diabetes Prevention Program Research Group. The prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes in the Diabetes Prevention Program. Diabet Med. 2007;24(2):137-144.
50. Fong DS, Aiello L, Gardner TW, et al; American Diabetes Association. Diabetic retinopathy. Diabetes Care. 2003;26:S99-S102.
51. Attebo K, Ivers RQ, Mitchell P. Refractive errors in an older population: the Blue Mountains Eye Study. Ophthalmology. 1999;106(6):1066-1072.
52. Liou HL, McCarty CA, Jin CL, Taylor HR. Prevalence and predictors of under-corrected refractive errors in the Victorian population. Am J Ophthalmol. 1999;127(5):590-596.
53. Muñoz B, West SK, Rodriguez J, et al. Blindness, visual impairment and the problem of uncorrected refractive error in a Mexican-American population: Proyecto VER. Invest Ophthalmol Vis Sci. 2002;43(3):608-614.
54. Robaei D, Huynh SC, Kifley A, Mitchell P. Correctable and non-correctable visual impairment in a population-based sample of 12-year-old Australian children. Am J Ophthalmol. 2006;142(1):112-118.
55. Dandona L, Dandona R, Naduvilath TJ, et al. Burden of moderate visual impairment in an urban population in southern India. Ophthalmology. 1999;106(3):497-504.
56. Foran S, Rose K, Wang JJ, Mitchell P. Correctable visual impairment in an older population: the Blue Mountains Eye Study. Am J Ophthalmol. 2002;134(5):712-719.
57. VanNewkirk MR, Weih L, McCarty CA, Taylor HR. Cause-specific prevalence of bilateral visual impairment in Victoria, Australia: the Visual Impairment Project. Ophthalmology. 2001;108(5):960-967.
58. Weih LM, Vannewkirk MR, McCarty CA, Taylor HR. Age-specific causes of bilateral visual impairment. Arch Ophthalmol. 2000;118(2):264-269.
59. Vitale S, Cotch MF, Sperduto R, Ellwein L. Costs of refractive correction of distance vision impairment in the United States, 1999. Ophthalmology. 2006;113(12):2163-2170.
60. Hodges LE, Berk ML. Unmet need for eyeglasses: results from the 1994 Robert Wood Johnson Access to Care Survey. J Am Optom Assoc. 1999;70(4):261-265.
61. American Diabetes Association. Standards of medical care in diabetes 2007. Diabetes Care. 2007;30(suppl 1):S4-S41.
62. American Optometric Association. Optometric clinical practice guideline: comprehensive adult eye and vision examination. http://www.aoa.org/documents/ CPG-1.pdf. Published 2005. Accessed November 19, 2006.
63. American Academy of Ophthalmology. Preferred practice pattern: comprehensive adult medical eye evaluation. http://one.aao.org/asset.axd?id= 6749e4a0-6a09-4795-8f8d-aec60dc937c9. Accessed November 19, 2006.
64. McCarty CA, Lloyd-Smith CW, Lee SE, Livingston PM, Stanislavsky YL, Taylor HR. Use of eye care services by people with diabetes: the Melbourne Visual Impairment Project. Br J Ophthalmol. 1998;82(4):410-414.
65. Zhang X, Saaddine JB, Lee PP, et al. Eye care in the United States: do we deliver to high-risk people who can benefit most from it? Arch Ophthalmol. 2007;125(3):411-418.
66. Goldzweig CL, Rowe S, Wenger NS, MacLean CH, Shekelle PG. Preventing and managing visual disability in primary care: clinical applications. JAMA. 2004;291(12):1497-1502.
67. Rowe S, MacLean CH, Shekelle PG. Preventing visual loss from chronic eye disease in primary care: scientific review. JAMA. 2004;291(12):1487-1495.
68. Javitt JC. Preventing blindness in Americans: the need for eye health education. Surv Ophthalmol. 1995;40(1):41-44.
69. Mitchell P, Hayes P, Wang JJ. Visual impairment in nursing home residents: the Blue Mountains Eye Study. Med J Aust. 1997;166(2):73-76.
70. Goss DA, Grosvenor T. Reliability of refraction-a literature review. J Am Optom Assoc. 1996;67(10):619-630.
71. Bush TL, Miller SR, Golden AL, Hale WE. Self-report and medical record report agreement of selected medical conditions in the elderly. Am J Public Health. 1989;79(11):1554-1556.
72. Harlow SD, Linet MS. Agreement between questionnaire data and medical records: the evidence for accuracy of recall. Am J Epidemiol. 1989;129(2):233-248.
73. Kehoe R, Wu S-Y, Leske MC, Chylack LT Jr. Comparing self-reported and physician-reported medical history. Am J Epidemiol. 1994;139(8):813-818.
74. Saydah SH, Geiss LS, Tierney E, Benjamin SM, Engelgau M, Brancati F. Review of the performance of methods to identify diabetes cases among vital statistics, administrative, and survey data Ann Epidemiol. 2004;14(7):507-516.